Medical Devices : Protecting Patients and Promoting Innovation.

China's Healthcare Sector, Drug Safety, and the U.S.-China Trade in Medical Products.
Published: (2014)

Medical devices and the FDA : regulation, user fees and tort claims /
Published: (2013)

Examining FDA's Medical Device User Fee Program.
Published: (2017)

Federal policies and the medical devices industry.
Published: (1984)

Federal policies and the medical devices industry.
Published: (1984)

FDA and the medical device industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 26, 1990.
Published: (1990)

FDA medical device approval : is there a better way? : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, June 2, 2011.
Published: (2011)

FDA medical device approval : is there a better way? : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, June 2, 2011.
Published: (2011)

Medical device reporting : improvements needed in FDA's system for monitoring problems with approved devices : report to congressional committees /
Published: (1997)

Medical devices : shortcomings in FDA's premarket review, postmarket surveillance, and inspections of device manufacturing establishments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /
by: Crosse, Marcia
Published: (2009)

Medical devices : protecting patients and promoting innovation : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... November 15, 2011.
Published: (2014)

Medical devices : FDA faces challenges in conducting inspections of foreign manufacturing establishments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /
by: Crosse, Marcia
Published: (2008)

Progress and Challenges : The State of Tobacco Use and Regulation in the United States.
Published: (2014)

FDA User Fee Agreements : Strengthening FDA and the Medical Products Industry for the Benefit of Patients.
Published: (2012)

Impact of medical device regulation on jobs and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, February 17, 2011.
Published: (2011)

Food and Drug enforcement standards for medical devices : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, September 14, 1995.
Published: (1997)

Medical devices : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred First Congress, second session, on examining proposed legislation to revise and strengthen the Food and Drug Administration's regulation of medical devices, July 25, 1990.
Published: (1991)

Regulation of Dietary Supplements.
Published: (2003)

Medical devices : technological innovation and patient/provider perspectives : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, May 30, 1997.
Published: (1997)

FDA's clearance of medical devices through the 510(k) process.
Published: (2013)

Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993.
Published: (1994)

Examining Medical Product Manufacturer Communications.
Published: (2017)

Reinventing drug and medical device regulation.
Published: (1995)

Reinventing regulation of drugs and medical devices.
by: Clinton, Bill, 1946-
Published: (1995)

A delicate balance : FDA and the reform of the medical device approval process : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, April 13, 2011.
Published: (2011)

Guidance for industry, FDA staff, and FDA-accredited third parties.
Published: (2009)

FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995.
Published: (1996)

Promotion of drugs and medical devices for unapproved uses : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991.
Published: (1992)

Examining the Implementation of the Food Safety Modernization Act.
Published: (2014)

Federal policies and the medical devices industry : summary.
Published: (1984)

Federal policies and the medical devices industry : summary.
Published: (1984)

Examining Improvements to the Regulation of Medical Technologies.
Published: (2017)

The Role and Performance of FDA in Ensuring Food Safety.
Published: (2010)

Protecting the Public Health : Examining FDA's Initiatives and Priorities.
Published: (2014)

Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization /
by: Thaul, Susan
Published: (2018)

Reprocessed Single-Use Medical Devices : FDA Oversight Has Increased, and Available Information Does Not Indicate That Use Presents an Elevated Risk.
Published: (2008)